logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Idiopathic Pulmonary Fibrosis Advances In Diagnostic Tools And Disease Management 1st Edition Hiroyuki Nakamura

  • SKU: BELL-5237998
Idiopathic Pulmonary Fibrosis Advances In Diagnostic Tools And Disease Management 1st Edition Hiroyuki Nakamura
$ 31.00 $ 45.00 (-31%)

5.0

110 reviews

Idiopathic Pulmonary Fibrosis Advances In Diagnostic Tools And Disease Management 1st Edition Hiroyuki Nakamura instant download after payment.

Publisher: Springer Japan
File Extension: PDF
File size: 5.9 MB
Pages: 260
Author: Hiroyuki Nakamura, Kazutetsu Aoshiba (eds.)
ISBN: 9784431555810, 4431555811
Language: English
Year: 2016
Edition: 1

Product desciption

Idiopathic Pulmonary Fibrosis Advances In Diagnostic Tools And Disease Management 1st Edition Hiroyuki Nakamura by Hiroyuki Nakamura, Kazutetsu Aoshiba (eds.) 9784431555810, 4431555811 instant download after payment.

From epidemiology and pathogenesis to disease management, this book reviews our current understanding of and provides up-to-date information of Idiopathic Pulmonary Fibrosis (IPF). A subtype of Idiopathic Interstitial Pneumonias (IIP), IPF is one of the most elusive and intractable respiratory disease to date and its triggering factors remain unclear. However, new developments such as serum markers that are highly specific to IPF (i.e. KL-6, SP-A, and SP-D), the establishment of systematic diagnostic imaging (HRCT) and accumulated reports of treatment using an antifibrotic agent (pirfenidone) are slowly improving our understanding of the disease. Edited by an established authority in the field and written by experts, this book will be valuable to not only to beginning learners but also to physicians, instructors and researchers whose work involves IIPs. With each chapter exploring critical questions, with unresolved issues and future prospects, the book offers a valuable resource for understanding issues such as the newly proposed entity of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema: CPFE) and the mechanism of how so many IIP sufferers develop lung cancer.

Related Products